These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38749802)

  • 1. Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and Physicians.
    Kuykendall AT; Fine JT; Kremyanskaya M
    Clin Lymphoma Myeloma Leuk; 2024 Aug; 24(8):512-522. PubMed ID: 38749802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.
    Crodel CC; Jentsch-Ullrich K; Reiser M; Jacobasch L; Sauer A; Tesch H; Ulshöfer T; Wunschel R; Palandri F; Heidel FH
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2693-2705. PubMed ID: 34807311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future treatment options for polycythemia vera.
    Griesshammer M; Gisslinger H; Mesa R
    Ann Hematol; 2015 Jun; 94(6):901-10. PubMed ID: 25832853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
    Sirhan S; Busque L; Foltz L; Grewal K; Hamm C; Laferriere N; Laneuville P; Leber B; Liew E; Olney HJ; Prchal J; Porwit A; Gupta V
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):715-27. PubMed ID: 26433906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A; Barbui T
    Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis.
    Handa S; Ginzburg Y; Hoffman R; Kremyanskaya M
    Curr Opin Hematol; 2023 Mar; 30(2):45-52. PubMed ID: 36728649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera.
    Reiter A; Harrison C
    Curr Hematol Malig Rep; 2016 Oct; 11(5):356-67. PubMed ID: 26894383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
    Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.
    Kremyanskaya M; Kuykendall AT; Pemmaraju N; Ritchie EK; Gotlib J; Gerds A; Palmer J; Pettit K; Nath UK; Yacoub A; Molina A; Saks SR; Modi NB; Valone FH; Khanna S; Gupta S; Verstovsek S; Ginzburg YZ; Hoffman R;
    N Engl J Med; 2024 Feb; 390(8):723-735. PubMed ID: 38381675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera: aspects of its current diagnosis and initial treatment.
    Silver RT; Abu-Zeinah G
    Expert Rev Hematol; 2023 Apr; 16(4):253-266. PubMed ID: 37013802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
    J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera.
    Podoltsev NA; Zhu M; Zeidan AM; Wang R; Wang X; Davidoff AJ; Huntington SF; Giri S; Gore SD; Ma X
    Blood Adv; 2018 Oct; 2(20):2681-2690. PubMed ID: 30333100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
    Streiff MB; Smith B; Spivak JL
    Blood; 2002 Feb; 99(4):1144-9. PubMed ID: 11830459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Therapeutic Approaches in Polycythemia Vera.
    Falchi L; Newberry KJ; Verstovsek S
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl(0):S27-33. PubMed ID: 26297275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Front-line therapy in polycythemia vera and essential thrombocythemia.
    Barbui T; Finazzi MC; Finazzi G
    Blood Rev; 2012 Sep; 26(5):205-11. PubMed ID: 22784966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts.
    Scherber RM; Geyer HL; Dueck AC; Kosiorek HE; Finazzi G; Cavazzina R; Masciulli A; Scarano M; Vannucchi AM; Mesa RA; Barbui T
    Leuk Lymphoma; 2017 Jun; 58(6):1481-1487. PubMed ID: 27830999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycythemia Vera (PV): Update on Emerging Treatment Options.
    Benevolo G; Vassallo F; Urbino I; Giai V
    Ther Clin Risk Manag; 2021; 17():209-221. PubMed ID: 33758507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.